US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 0.972
  • -0.003-0.29%
Close Dec 27 16:00 ET
  • 0.972
  • 0.0000.00%
Post 20:01 ET
44.45MMarket Cap-0.63P/E (TTM)

About Xilio Therapeutics Company

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Company Profile

SymbolXLO
Company NameXilio Therapeutics
Listing DateOct 22, 2021
Issue Price16.00
Founded2015
CEODr. Rene Russo, Pharm.D.
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address828 Winter Street,Suite 300
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-524-2466
Websitehttp://www.xiliotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Rene Russo, Pharm.D.
  • Director, Chief Executive Officer and President
  • 3.00M
  • Dr. Katarina Luptakova, M.D.
  • Chief Medical Officer
  • 932.17K
  • Christopher Frankenfield
  • Chief Operating Officer
  • 1.86M
  • Kevin M. Brennan
  • Senior Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer
  • --
  • Paul J. Clancy
  • Chairman of the Board
  • 96.77K
  • James Shannon, M.D.
  • Director
  • --
  • Tomas J. Heyman
  • Director
  • 77.27K
  • Robert Ross
  • Director
  • 66.77K
  • Dr. Yuan Xu, PhD
  • Director
  • 65.77K
  • Dr. Aoife Brennan, M.D.
  • Director
  • --
  • Sara M. Bonstein
  • Independent Director
  • 76.77K
  • Christina Rossi, M.B.A.
  • Independent Director
  • 78.05K
  • Daniel Curran
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data